About Haleon plc (HLN)
Haleon plc is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector.
HLN trades on the London Stock Exchange and is classified as a large-cap stock .
Key Statistics
- Current Price
- £319.40
- Market Cap
- £28.09B
- 52-Week High
- £433.60
- 52-Week Low
- £310.50
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
£1,000 Invested in Haleon plc (HLN)
How much would £1,000 invested in HLN be worth today?
What would £1,000 invested in HLN 1 year ago be worth today?
A £1,000 investment in Haleon plc (HLN) in 2025 would be worth £893 as of November 2026, representing a -10.7% total return.
What would £1,000 invested in HLN 3 years ago be worth today?
A £1,000 investment in Haleon plc (HLN) in 2023 would be worth £990 as of November 2026, representing a -1.0% total return.
What would £1,000 invested in HLN at IPO be worth today?
A £1,000 investment in Haleon plc (HLN) at IPO would be worth £1,037 as of November 2026, representing a +3.7% total return.
Monthly Returns Heatmap
Over the past 4+ years (51 months), Haleon plc (HLN) has averaged a monthly return of +0.34% with a median return of +0.51%. The stock had 28 positive months (55%) and 23 negative months (45%). The best month in HLN's history was December 2022 with a +15.2% return, while the worst was August 2022 at -11.3%. Historically, February tends to be the strongest month (averaging +3.9%), and October the weakest (-2.3%).
HLN's longest winning streak was 5 consecutive months of gains, while its longest losing streak was 3 consecutive months of losses. The best full year was 2024 with a cumulative return of +17.1%, and the worst was 2023 at -0.5%.
Annual Returns
Over 4 years of trading history, Haleon plc (HLN) has delivered an average annual return of +0.05% with a median return of -1.20%. The compound annual growth rate (CAGR) is -0.60%. The stock posted gains in 1 years (25%) and losses in 3 years (75%).
HLN's best year was 2024 with a +17.35% gain, while the worst was 2026 at -14.76%. The longest streak of consecutive positive years was 1, and the longest losing streak was 2 years. HLN achieved double-digit gains (10%+) in 1 years. It suffered double-digit losses in 1 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -14.76% | £374.73 | £319.40 |
| 2025 | -0.67% | £377.26 | £374.73 |
| 2024 | +17.35% | £321.47 | £377.26 |
| 2023 | -1.73% | £327.12 | £321.47 |
Frequently Asked Questions: HLN
What sector is HLN in? ▼
HLN operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has HLN performed historically? ▼
Over 4 years of trading history, HLN has posted gains in 1 years (25% of the time). The best year was 2024 with a +17.4% return. Past performance does not guarantee future results.
How can I invest in HLN? ▼
You can invest in HLN through any brokerage account that offers access to the London Stock Exchange. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold HLN.
Last updated: 11/1/2026